UY38507A - Método de extracción y composición así obtenida - Google Patents

Método de extracción y composición así obtenida

Info

Publication number
UY38507A
UY38507A UY0001038507A UY38507A UY38507A UY 38507 A UY38507 A UY 38507A UY 0001038507 A UY0001038507 A UY 0001038507A UY 38507 A UY38507 A UY 38507A UY 38507 A UY38507 A UY 38507A
Authority
UY
Uruguay
Prior art keywords
aqueous liquid
cannabinoids
extraction
component
plant substrate
Prior art date
Application number
UY0001038507A
Other languages
English (en)
Inventor
Giuseppe Cannazza
Cinzia Citti
Flavio Forni
Maria Angela Vandelli
Original Assignee
Giuseppe Cannazza
Cinzia Citti
Flavio Forni
Maria Angela Vandelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuseppe Cannazza, Cinzia Citti, Flavio Forni, Maria Angela Vandelli filed Critical Giuseppe Cannazza
Publication of UY38507A publication Critical patent/UY38507A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • B01D11/0288—Applications, solvents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Extraction Or Liquid Replacement (AREA)

Abstract

Método de extracción comprendiente una fase de extracción, durante la cual el sustrato vegetal es colocado a contacto con un líquido acuoso con el fin de extraer cannabinoides desde el sustrato vegetal y llevarlos en el componente liquido acuoso; el líquido acuoso comprende al menos el 40% en peso, con respeto al peso total del líquido acuoso, de agua y un componente complejante; el componente complejante es al menos una ciclodextrina; la composición obtenida es sorprendentemente estable y los cannabinoides extraídos, en particular los cannabinoides ácidos, que normalmente son inestables, pueden ser conservados por largos periodos de tiempo.
UY0001038507A 2018-12-11 2019-12-11 Método de extracción y composición así obtenida UY38507A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT201800010978 2018-12-11

Publications (1)

Publication Number Publication Date
UY38507A true UY38507A (es) 2020-07-31

Family

ID=65861560

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038507A UY38507A (es) 2018-12-11 2019-12-11 Método de extracción y composición así obtenida

Country Status (7)

Country Link
US (1) US20220023771A1 (es)
EP (1) EP3894036A2 (es)
CN (1) CN113543865A (es)
BR (1) BR112021011388A2 (es)
CA (1) CA3122481A1 (es)
UY (1) UY38507A (es)
WO (1) WO2020121218A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3160139A1 (en) * 2019-11-04 2021-05-14 Grow Biotech Plc Method for selective recovery of hydrophobic compounds
CN113880697A (zh) * 2021-11-15 2022-01-04 于立群 一种大麻二酚的提取方法
CN114588198A (zh) * 2022-03-29 2022-06-07 于立群 一种大麻二酚或大麻素酸的稳定方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1691954B (zh) * 2002-08-14 2010-12-08 Gw药品有限公司 对得自植物材料的药学活性大麻类物质的提取
GB2392093B (en) * 2002-08-14 2006-03-08 Gw Pharma Ltd Pharmaceutical formulations
CN102905565B (zh) * 2010-05-21 2016-08-24 环球蒸汽商标公司 制备用于电吸烟设备的烟草提取物的方法
KR101875984B1 (ko) * 2010-09-07 2018-07-06 레제네라 파마 리미티드 매스틱 검의 산성 추출물을 포함하는 조성물
CN105764504A (zh) * 2013-09-26 2016-07-13 罗纳德·D·塞库拉 引入大麻种衍生的植物药品的局部治疗
US20170340562A9 (en) * 2014-05-12 2017-11-30 Hddc Holdings Llc Cannabinoid caffeinated drinks, powder, beans, and cannabinoid loose tea leaf
MA37112B1 (fr) * 2014-06-06 2016-08-31 Univ Alakhawayn Nouveau procede d'extraction et de purification de cannabinoides
UY36530A (es) * 2015-01-22 2016-08-31 Phytoplant Res S L Métodos para purificar cannabinoides, composiciones y kits de estos
IL248150B (en) * 2016-09-29 2018-05-31 Garti Nissim A method for selective extraction of cannabinoid from plant origin
CN108310799A (zh) * 2017-01-17 2018-07-24 中国科学院大学 一种基于β-环糊精协助提取类似古代茶叶残留物的方法
MX2019009642A (es) * 2017-02-15 2019-11-11 Molecular Infusions Llc Formulaciones.

Also Published As

Publication number Publication date
WO2020121218A3 (en) 2020-07-23
CA3122481A1 (en) 2020-06-18
US20220023771A1 (en) 2022-01-27
CN113543865A (zh) 2021-10-22
BR112021011388A2 (pt) 2021-08-31
WO2020121218A2 (en) 2020-06-18
EP3894036A2 (en) 2021-10-20

Similar Documents

Publication Publication Date Title
UY38507A (es) Método de extracción y composición así obtenida
RU2016149657A (ru) Жидкий состав, содержащий никотин, для введения в виде аэрозоля
PE20142183A1 (es) Combinaciones de compuestos antifungicos y aceite del arbol del te
PE20191714A1 (es) Nanoparticula polimerica de finasterida y minoxidil, proceso de preparacion, suspension acuosa conteniendo la misma, composicion farmaceutica, y su uso
UY38075A (es) Composiciones anticonceptivas con efectos cardiovasculares reducidos
CO7240366A2 (es) Activación ácido-orgánica de persulfatos
AR094524A1 (es) Procesos, método y sistema para separar mercurio de fluidos
CL2016002224A1 (es) Método de obtención de un recubrimiento inorgánico para partículas a base de nitrato de amonio.
UY36703A (es) Composiciones y métodos para la administración de un polinucleótido en una planta
CL2011001132A1 (es) Metodo para reducir al minimo la inflamacion en el sitio de inyeccion durante la administracion subcutanea de una macromolecula que comprende agregar a una formulacion que contiene la macromolecula de 2% a 30% de ciclodextrina; formulacion que comprende un anticuerpo; y metodo para reducir al minimola precipitacion del anticuerpo.
BR112016022394A2 (pt) Composição farmaceuticamente aceitável, composição na forma de uma solução injetável farmaceuticamente aceitável, uso da composição, e, método para a preparação da composição injetável farmaceuticamente aceitável
UA114123C2 (xx) Водна композиція диклофенаку
AR095782A1 (es) Método de fabricacion de un concentrado
PE20212103A1 (es) Mezclas y composiciones que comprenden 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2-ona, y metodos de uso de los mismos
WO2016153211A3 (ko) 감귤류 과피 추출물의 제조방법 및 간 손상 예방, 개선 또는 치료용 조성물
AR096260A1 (es) Inhibidor de la corrosión de henna para un ácido en un pozo
AR101136A1 (es) Proceso para la preparación de ácidos 3-hidroxipicolínicos
BR112017017747A2 (pt) processo de preparação de um extrato de matriz vegetal com um composto anfifílico não iônico como adjuvante de extração em meio aquoso
AR115554A1 (es) Proceso contra corriente de separación de tierras raras
BR112016006383A2 (pt) método de extração de proteína
CO2019003405A2 (es) Composiciones isotópicas
AR098351A1 (es) Sistema ruptor doble para reducir los daños en las formaciones durante la fracturación
AR089831A1 (es) Una composicion y un metodo para tratar sustratos
AR106819A1 (es) Composición de polímero de cloruro de vinilideno que comprende al menos un éster de sorbato
PE20170933A1 (es) Estrategia ultravioleta para repelencia aviar